Published in Medical Letter on the CDC and FDA, February 15th, 2009
“The appointments of Mike and Elaine are another step in our ongoing commitment to continuous improvement in Spectranetics’ compliance programs,” said Emile Geisenheimer, Chairman, President and Chief Executive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.